Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Apr 25, 2025

Featuring an interview with Dr Adam M Brufsky, including the following topics:

  • Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00)
  • Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52)
  • Clinical Investigator Survey Results (10:05)

CME information and select publications